Author:
Yakoob Javed,Abid Shahab,Jafri Wasim,Abbas Zaigham,Mumtaz Khalid,Hamid Saeed,Ahmed Rashida
Abstract
Abstract
Background
The aim was to investigate the reinfection rate of H. pylori during a follow-up period of 12 months in adults who had undergone eradication therapy.
Methods
One hundred-twenty patients; 116 with gastritis, 3 with duodenal ulcer and 1 gastric ulcer, were studied. Their mean age was 41 ± 13 years (range 18–77) and male: female ratio of 2:1. H. pylori were cultured and antibiotic sensitivity was determined by Epsilometer test (E-test) for clarithromycin (CLR) and amoxicillin (AMX). Primers of urease C gene of H. pylori and Sau-3 and Hha I restriction enzymes were used for polymerase chain reaction-restriction fragment length polymorphism analysis (PCR-RFLP). 14C urea breath test (14C-UBT) was performed 4 weeks after the eradication therapy. The successfully treated patients were observed for 12 months with 14C-UBT to assess H. pylori status. If 14C-UBT was negative, it was repeated after every 12 weeks. If 14C-UBT was positive, endoscopy was repeated with biopsies.
Result
The eradication therapy was successful in 102(85%) patients. Out of forty-seven H. pylori isolates cultured, clarithromycin sensitivity was present in 30(64%) and amoxicillin in 45(98%), respectively. Follow-up 14C-urea breath tests of all 102 patients who eradicated H. pylori remained negative up to 9 months. However, in 6 patients, the 14C-UBT confirmed recurrence at 12 months. The recurrence rate was 6%.
Conclusion
A low rate of recurrence of H. pylori infection was found in patients with dyspeptic symptoms. H. pylori isolates demonstrated a high invitro clarithromycin resistance.
Publisher
Springer Science and Business Media LLC
Subject
Gastroenterology,General Medicine
Reference40 articles.
1. Anon: NIH consensus conference. Helicobacter pylori in peptic ulcer disease. NIH consensus development panel on helicobacter pylori in peptic ulcer disease. JAMA. 1994, 272: 65-69. 10.1001/jama.1994.03520010077036.
2. Sipponen P: Gastric cancer: a long term consequence of H. pylori infection?. Scand J Gastroenterol. 1994, 29: 24-27.
3. Mera R, Fontham ET, Bravo LE, Bravo JC, Piazuelo MB, Camargo MC, Correa P: Long term follow up of patients treated for helicobacter pylori infection. Gut. 2005, 54: 1536-1540. 10.1136/gut.2005.072009.
4. Kyzekova J, Mour J: The effect of eradication therapy on histological changes in the gastric mucosa in patients with non-ulcer dyspepsia and helicobacter pylori infection. Prospective randomized intervention study. Hepatogastroenterology. 1999, 46: 2048-2056.
5. Larkin CJ, Watson P: Gastric corpus atrophy following eradication of helicobacter pylori. Eur J Gastroenterol Hepatol. 2001, 13: 377-382. 10.1097/00042737-200104000-00012.
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献